What's new? Log in Free sign up

Filing search / Alkermes plc / "Hire"

Search information

Alkermes plc

Companies

"Hire"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

49 results

Newest first Best match first

ALKS Alkermes plc

to attract, hire, develop, recognize and retain qualified and highly skilled employees with experience in areas such as R&D, including early discovery … budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes

12 Feb 25

5:18pm

ALKS Alkermes plc

Quarterly report

and Mural are also each subject to mutual six-month employee non-solicitation and non-hire restrictions, subject to certain customary exceptions, and certain

1 May 24

5:14pm

ALKS Alkermes plc

Quarterly report

, lease, take in exchange, hire or otherwise acquire any personal property and any rights or privileges that the Company considers necessary

1 May 24

5:14pm

ALKS Alkermes plc

Definitive proxy

Hire Grant Date”, for all equity-eligible new hires who began their employment the prior month. The Limited Compensation Sub-Committee’s current … approval authority is for new hire employees whose job level is below the level of Senior Vice President and for equity awards of up to $550,000

15 Apr 24

4:18pm

ALKS Alkermes plc

Preliminary proxy

if such first Wednesday is a holiday), referred to as the “New Hire Grant Date”, for all equity-eligible new hires who began their employment the prior month … . The Limited Compensation Sub-Committee’s current approval authority is for new hire employees whose job level is below the level of Senior Vice

5 Apr 24

5:28pm

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

1qnz5pkey1hfbn8hhwc

21 Feb 24

4:01pm

1zqde5rxaxmaegs60ej

21 Feb 24

4:01pm

21 Feb 24

4:01pm

Alkermes Completes Separation of Oncology Business

h1bbec yc2to7rj

Alkermes Completes Separation of Oncology Business

ejwifd8jfs3 8rw

Quarterly report

25 Oct 23

4:05pm

jhnofonl6kipkjeuc

Proxy in contested solicitation

5hu3ew23o6g9iim8dhe2

Preliminary revised proxy

wng39uyue2j50 2m

Preliminary proxy with contested solicitation

Annual report (amended)

26 Apr 23

4:18pm

88ky rt5l5jdsr2si4

Quarterly report

27 Jul 22

9:21am

Proxy in contested solicitation

Additional proxy soliciting materials

Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.